Advertisement

Late-Breaking Data Prove Efficacy of Subcutaneous Secukinumab in Psoriatic Arthritis

At the 2017 annual meeting of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP), researchers presented late-breaking evidence that two dose levels of subcutaneous secukinumab inhibit structural damage in patients with psoriatic arthritis (PsA).

Joint Damage in Healthy Military Recruits May Mimic Spondyloarthropathies

Research highlighted at the 2017 annual meeting of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP) encourages rheumatologists to exercise caution when interpreting magnetic resonance imaging (MRI) scans for the diagnosis of axial spondyloarthritis (SpA), an inflammatory disease with the main symptom of pain in the lower back.

What Drives Healthcare Costs in Rheumatoid Arthritis?

Rheumatoid arthritis (RA) is associated with high healthcare resource utilization. Research presented at the 2017 annual meeting of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP) aimed to identify what factors drive and determine healthcare costs in that patient population.

Late-Breaking Research Shows Four-Year Efficacy and Safety of Secukinumab in Patients with Ankylosing Spondylitis

On Tuesday at the 2017 annual meeting of the American College of Rheumatology (ACR) and the Association of Rheumatology Health Professionals (ARHP), researchers presented late-breaking data from an extension of the MEASURE 1 study, demonstrating that secukinumab, a fully human anti-interleukin-17A monoclonal antibody, is safe and effective over four years in patients with ankylosing spondylitis (AS), a form of arthritis that primarily affects the spine.

Young Athletes Commonly Develop Bone Marrow Edema in the Joints of the Lower Spine

Researchers from Denmark studied a population of runners and ice hockey players, finding that young athletes commonly experience accumulation of excessive fluid in their sacroiliac joints, most frequently in the posterior lower ilium, or the lowest part of the spine where it connects to the pelvis.
Advertisement